188 related articles for article (PubMed ID: 38674331)
1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract][Full Text] [Related]
2. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
4. Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data.
Budczies J; Pfarr N; Romanovsky E; Endris V; Stenzinger A; Denkert C
BMC Bioinformatics; 2018 Apr; 19(1):157. PubMed ID: 29699497
[TBL] [Abstract][Full Text] [Related]
5. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
[No Abstract] [Full Text] [Related]
6. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
[TBL] [Abstract][Full Text] [Related]
7. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
[TBL] [Abstract][Full Text] [Related]
9. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
10. Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer.
Lee YJ; Kim D; Kim HS; Na K; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
Yonsei Med J; 2019 Oct; 60(10):914-923. PubMed ID: 31538426
[TBL] [Abstract][Full Text] [Related]
11. Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
Kim HY; Choi JW; Lee JY; Kong G
Oncotarget; 2017 Apr; 8(16):27277-27285. PubMed ID: 28460482
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome.
Kim YJ; Jung SH; Hur EH; Choi EJ; Lee KH; Park HC; Kim HJ; Kwon YR; Park S; Lee SH; Chung YJ; Lee JH
Leuk Res; 2021 Apr; 103():106540. PubMed ID: 33667811
[TBL] [Abstract][Full Text] [Related]
13. BRACNAC: A
Kechin A; Boyarskikh U; Borobova V; Khrapov E; Subbotin S; Filipenko M
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068953
[TBL] [Abstract][Full Text] [Related]
14. Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
[TBL] [Abstract][Full Text] [Related]
15. Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
Kaur P; Porras TB; Ring A; Carpten JD; Lang JE
Sci Rep; 2019 Feb; 9(1):1482. PubMed ID: 30728399
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
17. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
18. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
19. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.
Grasso C; Butler T; Rhodes K; Quist M; Neff TL; Moore S; Tomlins SA; Reinig E; Beadling C; Andersen M; Corless CL
J Mol Diagn; 2015 Jan; 17(1):53-63. PubMed ID: 25468433
[TBL] [Abstract][Full Text] [Related]
20. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
